We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
MedAdvisor is a health information services business based in Australia. MedAdvisor shares (MDR) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. MedAdvisor has a trailing 12-month revenue of around $64.5 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Best overall broker
Our top pick for
Best low-cost broker
| 52-week range | $0.135 - $0.415 |
|---|---|
| 50-day moving average | $0.2085 |
| 200-day moving average | $0.3053 |
| Target price | $0.4 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.037 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.145
| 1 week (2022-06-20) | 0.145 |
|---|---|
| 1 month (2022-05-27) | -26.58% |
| 3 months (2022-03-28) | -48.67% |
| 6 months (2021-12-24) | -59.72% |
| 1 year (2021-06-28) | -50.85% |
|---|---|
| 2 years (2020-06-26) | -71.57% |
| 3 years (2019-06-28) | -94.20% |
| 5 years (2017-06-27) | -90.45% |
| Revenue TTM | $64.5 million |
|---|---|
| Gross profit TTM | $-2,136,967 |
| Return on assets TTM | -11.89% |
| Return on equity TTM | -30.8% |
| Profit margin | -21.25% |
| Book value | 0.113 |
| Market capitalisation | $59 million |
TTM: trailing 12 months
We're not expecting MedAdvisor to pay a dividend over the next 12 months.
MedAdvisor 's shares were split on a 1:7 basis on 20 November 2019. So if you had owned 7 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your MedAdvisor shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for MedAdvisor shares which in turn could have impacted MedAdvisor 's share price.
Over the last 12 months, MedAdvisor 's shares have ranged in value from as little as $0.135 up to $0.415. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while MedAdvisor 's is 0.2546. This would suggest that MedAdvisor 's shares are less volatile than average (for this exchange).
MedAdvisor Limited, together with its subsidiaries, develops and delivers software for personal medication management in Australia, the United States, the United Kingdom, and Asia. The company provides MedAdvisor, a medication and adherence platform that focuses on improving health outcomes by connecting health professionals with their patients using technology and enhancing medication adherence through health programs using mobile and web apps. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
Steps to owning and managing The Lottery Corporation shares.
Steps to owning and managing Endeavour Group shares.
